Original, respected and reliable market reports that provide critical business insights to the prospects for, and risks in, leading pharmaceutical markets.
Espicom’s Pharmaceutical Market Outlook reports have been used by senior management in commerce and industry for 30 years. Why? Because our experienced team of researchers and analysts combine economic, scientific and language skills to produce a critical evaluation of the operating environment for pharmaceutical companies.
An unmatched level of intelligence sourcing
Our full time team of experts regularly access over 1,200 primary source information points, including regulatory authorities, health organisations, statistics offices and industry. Much of the information in the Pharmaceutical Market Outlook reports is not readily available in English elsewhere. Espicom partners with the widely regarded Economist Intelligence Unit (EIU) to provide up-to-date economic and demographic data – a constant requirement in these rapidly changing times.
Detailed analysis and novel forecasts
Assembling comprehensive data is one thing, but our strength lies in its interpretation. What does it mean and what are the implications for operations and business development? Our analysis is second to none and the economic and market forecasts are built on solid research principles and continually assessed to reflect current and anticipated market conditions.
By 2016, the global pharmaceutical market, including pharmacy and hospital sales, is forecast to be worth around US$1.6 trillion at retail prices. High growth in emerging markets will leverage slow growth in developed markets. Cost-containment policies will be offset against market demands for more effective products. Health access will expand, due to increasing generic penetration.
The local market is the operating environment in which companies have to work. Domestic priorities set the agenda that affects a company’s operations, therefore the prevailing macroenvironment needs to be both understood and planned for. In this way, pharmaceutical companies have strengthened their capabilities to increase sales in local and international markets.
Beyond BRIC markets
The USA will continue to be the first worldwide economy, but other emerging markets will perform well, led by China, India, Russia and Brazil. However, a second wave of emerging markets will arise, namely South Korea, Mexico, Turkey and Indonesia. In an environment that is becoming more regulated, pharmaceutical producers are re-aligning their global strategies.
Quality information = business confidence
Any investment in market information must make a real return in terms of market knowledge and business efficiency. That demands the data is of the highest quality, thoroughly researched with primary sources and with insightful analysis and forecasts. Our team of analysts work full time to produce pharmaceutical market information that is second to none. With Pharmaceutical Market Outlook you get comprehensive market evaluation on which you can rely. Guaranteed.
About Pharmaceutical Market Outlook
Pharmaceutical Market Outlook is a pharmaceutical market evaluation service published by Espicom Business Intelligence. It covers over 60 key pharmaceutical markets worldwide.
|The Outlook for Pharmaceuticals in Central and Eastern Europe||The Outlook for Pharmaceuticals in Northern Europe||The Outlook for Pharmaceuticals in Western Europe|
|The Outlook for Pharmaceuticals in Central Asia||The Outlook for Pharmaceuticals in South East Asia||The Outlook for Pharmaceuticals in North East Asia|
|The Outlook for Pharmaceuticals in Latin America||E7: The Outlook for Pharmaceuticals||The Market for Pharmaceuticals in Brazil, Russia, India & China|
Mix and Match: If you have a specific need then you can build a custom set of market reports. Any number of markets can be included and a discount scheme means they are cost effective as well. For details please contact either the UK or US office. Full contact details are provided on our contact us page.
“We can get all this information off the Internet”
Very unlikely. Much of the analysis and forecasts in Pharmaceutical Market Outlook reports are unique – not to be found elsewhere. Furthermore, much of that information is not readily available in the public domain and some of it not available in English. While some sources of information on the Internet are trustworthy, others are not. Data is not always updated, and one must be ever cautious. Pharmaceutical Market Outlook analysts are in regular and routine contact with over 1200 key information sources in commerce and government including health ministries, companies, trade associations and statistics offices.